Clinical Trial Update: Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures [EARLY_Phase 1]

View source ↗

Summary

This document describes a NOT_YET_RECRUITING Phase 1 pilot study evaluating Panitumumab-IRDye800 as an optical imaging agent to detect intracranial lesions duri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Glioblastoma
• Meningioma
• Pituitary Adenoma
• Vestibular Schwannoma

Drugs mentioned

• Panitumumab-IRDye800

Snippet

Sponsor: Eben Rosenthal | Conditions: Meningioma, Glioblastoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING